Q1

Onesource Specialty Pharma Ltd

ONESOURCEFY2604 Aug 2025

Revenue-23.2%

Net Profit-100.2%

OPM26.16%

P&L

Quarterly Consolidated

Revenue

-23.2%327.27

Expenditure

-3.3%334.07

Net Profit

-100.2%-0.19

NPM -0.06%-100.3%EPS ₹0.02-99.8%

vs Q4 FY25

Informational and educational content only. Not investment advice.